Altimmune
ALT2.9606.86% ( +0.190 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Altimmune(ALT) predict that the EBIT is -24.24 M (-11.13%), Beat estimate;the EPS is -0.18 (+30.77%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B77.80%
----
EBITExceed expectations
-0.02B11.13%
-0.03B29.78%
+0.00B18.65%
EPSExceed expectations
-0.1830.77%
-0.24794.66%
+0.067926.11%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf